FDA Inspection
Ionetix CorporationIonetix Corporation – FDA Inspection, Sep 26, 2025
Record Details
This FDA Inspection record concerns Ionetix Corporation, with an inspection on September 26, 2025, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 3beb911b-7f69-4cdd-96dd-1bdc10c16a99
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1283830
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination
- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.40(a)Written procedures for control of components, containers, and closures
- 21 CFR 212.40(c)Use of reliable suppliers
- 21 CFR 212.10Lack Adequate Resources, Facilities, Equipment.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ionetix Corporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 14, 2023 | Not classified | Florida District Office |
Other documents for Ionetix Corporation
- FDA Inspection 1227483 - 2023-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.